发明名称 |
COMBINATION CANCER TREATMENT |
摘要 |
Described herein is TRAIL receptor targeting therapy in combination with metformin for treatment of cancer in humans. Using TRAIL receptor targeting therapy such as the TRAIL molecule, agonistic human monoclonal antibodies against TRAIL receptors, or peptides targeting TRAIL receptors in combination with metformin for the treatment of all types of cancer allows to obtain an optimum therapeutical effect at any time of the progression of the disease. |
申请公布号 |
US2017049725(A9) |
申请公布日期 |
2017.02.23 |
申请号 |
US201514706086 |
申请日期 |
2015.05.07 |
申请人 |
WISCONSIN ALUMNI RESEARCH FOUNDATION |
发明人 |
Cryns Vincent Leonard;Malin Dmitry;Strekalova Elena |
分类号 |
A61K31/155;A61K39/395;A61K38/17 |
主分类号 |
A61K31/155 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating cancer in a human individual in need of treatment for cancer, comprising co-administering metformin and a TRAIL receptor agonist, wherein the metformin is administered in an effective amount to sensitize cancer cells to the TRAIL receptor agonist. |
地址 |
Madison WI US |